PO

Polaris AI Pharma Corp.

Develops, manufactures, and supplies APIs and fine chemicals for generic drugs.

041910 | KO

Overview

Corporate Details

ISIN(s):
KR7041910001
LEI:
Country:
South Korea
Address:
경기도 화성시 향남읍 발안공단로 25, 화성시

Description

Polaris AI Pharma Corp., formerly known as ESTECHPHARMA CO., LTD, is a company engaged in the development, manufacture, and supply of active pharmaceutical ingredients (APIs) and fine chemicals. The company specializes in producing raw materials for generic drugs across various therapeutic categories. Its product portfolio includes APIs for treatments such as anti-thrombosis, anti-ulcer, asthma, and alcohol dependence.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-02-29 00:00
주식등의대량보유상황보고서(일반)
Korean 103.8 KB
2024-02-29 00:00
[기재정정]최대주주변경을수반하는주식양수도계약체결
Korean 27.5 KB
2024-02-22 00:00
현금ㆍ현물배당결정
Korean 8.5 KB
2024-02-22 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.1 KB
2023-12-27 00:00
[기재정정]사업보고서 (2022.12)
Korean 1.1 MB
2023-12-27 00:00
[기재정정]사업보고서 (2022.12)
Korean 1.1 MB
2023-12-26 00:00
[기재정정]사업보고서 (2020.12)
Korean 1.6 MB
2023-12-26 00:00
[기재정정]사업보고서 (2021.12)
Korean 1.7 MB
2023-12-15 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2023-11-14 00:00
분기보고서 (2023.09)
Korean 813.7 KB
2023-09-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB
2023-08-14 00:00
반기보고서 (2023.06)
Korean 763.9 KB
2023-05-12 00:00
분기보고서 (2023.03)
Korean 743.3 KB
2023-05-12 00:00
[기재정정]분기보고서 (2023.03)
Korean 745.9 KB
2023-03-23 00:00
정기주주총회결과
Korean 23.9 KB

Automate Your Workflow. Get a real-time feed of all Polaris AI Pharma Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Polaris AI Pharma Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Polaris AI Pharma Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.